TY - JOUR T1 - Genetic Underpinnings of Regional Adiposity Distribution in African Americans: Assessments from the Jackson Heart Study JF - medRxiv DO - 10.1101/2020.10.27.20220517 SP - 2020.10.27.20220517 AU - Mohammad Y. Anwar AU - Laura M. Raffield AU - Leslie A. Lange AU - Adolfo Correa AU - Kira C. Taylor Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/11/01/2020.10.27.20220517.abstract N2 - Background African ancestry individuals with comparable overall anthropometric measures to Europeans have lower abdominal adiposity. To explore genetic underpinning of different adiposity patterns, we investigated if genetic risk scores for well-studied adiposity phenotypes also predict other adiposity measures in 2420 African American individuals from the Jackson Heart Study.Methods Polygenic risk scores (PRS) for BMI, WHR adjusted for BMI (WHRBMIadj), WCBMIadj, and body fat percentage (BF%) were calculated using GWAS significant variants from mostly European ancestry studies. Associations between each PRS and adiposity measures were examined using multivariable linear regression.Results The BMI-PRS was found to be a positive predictor of BF% (β=0.005 per allele, 95% CI: 0.002, 0.008) and subcutaneous adiposity (β=0.004, CI: 0.002, 0.008). The BF%-PRS was associated with subcutaneous (β=0.022, CI: 0.010, 0.032) but not visceral adiposity; neither BMI nor BF%-PRS were predictors of central obesity measures. Other PRS were not associated with BF%.Conclusion These analyses suggest: (a) genetically driven increases in BF% strongly associate with subcutaneous but not visceral adiposity; (b) BF% is strongly associated with BMI but not central adiposity associated genetic variants. How these variants may contribute to observed differences in adiposity patterns between African and European ancestry individuals requires further study.Competing Interest StatementThe authors have declared no competing interest.Funding StatementLMR was supported by T32 HL129982.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All participants provided written informed consent. This analysis were reviewed and approved by the Institutional Review Boards at Jackson State University, Tougaloo College, and the University of Mississippi Medical Center.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author (MYA), as well as Jackson Heart Study and will be provided upon reasonable request. Codes used for statistical analysis are available from the corresponding author (MYA) and will be provided upon request. https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000286.v6.p2 ER -